share_log

bluebird bio | 8-K: Current report

bluebird bio | 8-K: Current report

bluebird bio | 8-K：重大事件
美股SEC公告 ·  2024/12/14 05:08

Moomoo AI 已提取核心訊息

bluebird bio executed a 1-for-20 reverse stock split on December 12, 2024, effective at 5:00 p.m. Eastern Time. The company's common stock began trading on a split-adjusted basis on The Nasdaq Global Select Market on December 13, 2024, under the existing symbol "BLUE". The new CUSIP number for the common stock is 09609G 209.The reverse split was approved by stockholders on December 4, 2024, with the board selecting the 1-for-20 ratio from a range of 1-for-15 to 1-for-20. Every 20 shares of issued and outstanding common stock were automatically converted into one share. The number of authorized shares and par value remain unchanged. No fractional shares will be issued; stockholders entitled to fractional shares will receive cash payments instead.The company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation with the Delaware Secretary of State to effect this change. This action may impact the company's future results, performance, or achievements, as noted in the forward-looking statements section of the announcement.
bluebird bio executed a 1-for-20 reverse stock split on December 12, 2024, effective at 5:00 p.m. Eastern Time. The company's common stock began trading on a split-adjusted basis on The Nasdaq Global Select Market on December 13, 2024, under the existing symbol "BLUE". The new CUSIP number for the common stock is 09609G 209.The reverse split was approved by stockholders on December 4, 2024, with the board selecting the 1-for-20 ratio from a range of 1-for-15 to 1-for-20. Every 20 shares of issued and outstanding common stock were automatically converted into one share. The number of authorized shares and par value remain unchanged. No fractional shares will be issued; stockholders entitled to fractional shares will receive cash payments instead.The company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation with the Delaware Secretary of State to effect this change. This action may impact the company's future results, performance, or achievements, as noted in the forward-looking statements section of the announcement.
bluebird bio於2024年12月12日下午5:00（東部時間）實施了1對20的反向拆股。公司的普通股於2024年12月13日在納斯達克全球精選市場根據拆分調整後的基礎上開始交易，現有標的爲"BLUE"。普通股的新CUSIP編號爲09609G 209。反向拆股於2024年12月4日得到股東批准，董事會從1對15到1對20的區間中選擇了1對20的比例。每20股已發行和流通的普通股自動轉換爲一股。授權股份和麪值保持不變。不會發行碎股；有權獲得碎股的股東將以現金支付作爲補償。公司向特拉華州國務卿提交了其修訂和重述的公司章程的修正證書，以實施此變更。正如公告中的前瞻性聲明部分所指出的，這一行動可能影響公司的未來業績、表現或成就。
bluebird bio於2024年12月12日下午5:00（東部時間）實施了1對20的反向拆股。公司的普通股於2024年12月13日在納斯達克全球精選市場根據拆分調整後的基礎上開始交易，現有標的爲"BLUE"。普通股的新CUSIP編號爲09609G 209。反向拆股於2024年12月4日得到股東批准，董事會從1對15到1對20的區間中選擇了1對20的比例。每20股已發行和流通的普通股自動轉換爲一股。授權股份和麪值保持不變。不會發行碎股；有權獲得碎股的股東將以現金支付作爲補償。公司向特拉華州國務卿提交了其修訂和重述的公司章程的修正證書，以實施此變更。正如公告中的前瞻性聲明部分所指出的，這一行動可能影響公司的未來業績、表現或成就。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間